Most of the KRAS inhibitors that have produced clinical data in biliary tract cancer so far target KRAS G12C, a mutation found in only a minority of patients with KRAS-mutant dise ...

The Supreme Court has sought a response from the Delhi government regarding allegations of non-compliance with EWS treatment ...

Supreme Court ne ILBS se EWS quota aur fund mismanagement par jawab manga hai. Kya hospital ne garibon ka haq mara? Agli ...

India, Oct. 1 -- In a significant development, the Supreme Court on Wednesday sought the Delhi government's response on a ...

Primary biliary cholangitis, or PBC, affects less than 1% of the population. Doctors do not know exactly what causes it, and ...

Radiotherapy remains one of the most widely deployed weapons in oncology, with more than half of all cancer patients ...

Explore precision oncology after chemoimmunotherapy in biliary tract cancer, including targeted therapy for IDH1, FGFR2, HER2 ...

Australians are being urged not to dismiss persistent exhaustion as new research exposes limited awareness of Primary Biliary ...

Biliary tract cancer, a family of rare and aggressive malignancies arising from the epithelial cells of the bile ducts and gallbladder, has long been one of the most difficult cancers to treat. Now, ...

Turning discarded bile into a source of genomic informationDistinguishing malignant from benign biliary strictures remains a major clinical challenge ...

Distinguishing malignant from benign biliary strictures remains a major clinical challenge. Endoscopic retrograde ...

It results from a slow, progressive destruction of the small bile ducts of the liver, causing bile and other toxins to build up in the liver, a condition called cholestasis. Further slow damage to the ...